185 related articles for article (PubMed ID: 38148013)
21. Apoptosis and cell cycle-related genes and proteins in classical Hodgkin lymphoma: application of tissue microarray technique.
Wang J; Taylor CR
Appl Immunohistochem Mol Morphol; 2003 Sep; 11(3):206-13. PubMed ID: 12966346
[TBL] [Abstract][Full Text] [Related]
22. Analysis of Epstein-Barr virus strains and variants in classical Hodgkin's lymphoma by laser microdissection.
García-Cosío M; Santón A; Martín P; Reguero ME; Cristóbal E; Bellas C
Histol Histopathol; 2008 Feb; 23(2):209-17. PubMed ID: 17999377
[TBL] [Abstract][Full Text] [Related]
23. Epstein-Barr virus-positive nodular lymphocyte predominant Hodgkin lymphoma.
Wang S; Medeiros LJ; Xu-Monette ZY; Zhang S; O'Malley DP; Orazi A; Zuo Z; Bueso-Ramos CE; Yin CC; Liu Z; Miranda RN; Young KH
Ann Diagn Pathol; 2014 Aug; 18(4):203-9. PubMed ID: 24852241
[TBL] [Abstract][Full Text] [Related]
24. Tumor-associated macrophages in pediatric classical Hodgkin lymphoma: association with Epstein-Barr virus, lymphocyte subsets, and prognostic impact.
Barros MH; Hassan R; Niedobitek G
Clin Cancer Res; 2012 Jul; 18(14):3762-71. PubMed ID: 22645050
[TBL] [Abstract][Full Text] [Related]
25. Down-regulation of the TGF-beta target gene, PTPRK, by the Epstein-Barr virus encoded EBNA1 contributes to the growth and survival of Hodgkin lymphoma cells.
Flavell JR; Baumforth KR; Wood VH; Davies GL; Wei W; Reynolds GM; Morgan S; Boyce A; Kelly GL; Young LS; Murray PG
Blood; 2008 Jan; 111(1):292-301. PubMed ID: 17720884
[TBL] [Abstract][Full Text] [Related]
26. Hodgkin lymphoma in Pakistan: an analysis of subtypes and their correlation with Epstein Barr virus.
Fatima S; Ahmed R; Ahmed A
Asian Pac J Cancer Prev; 2011; 12(6):1385-8. PubMed ID: 22126469
[TBL] [Abstract][Full Text] [Related]
27. A malignant lymphoma with histological features and immunophenotypic profile intermediate between EBV-positive diffuse large B-cell lymphoma and EBV-positive classical Hodgkin lymphoma in a 67-year-old female: a "gray zone" lymphoma associated with Epstein-Barr virus in the elderly.
Wang E; Papavassiliou P; Sebastian S
Pathol Res Pract; 2012 Jun; 208(6):363-7. PubMed ID: 22572037
[TBL] [Abstract][Full Text] [Related]
28. EBV-positive nodular lymphocyte predominant Hodgkin lymphoma: a single institution experience.
Fei F; Kiruthiga KG; Younes S; Natkunam Y
Hum Pathol; 2022 Nov; 129():32-39. PubMed ID: 35987347
[TBL] [Abstract][Full Text] [Related]
29. Tumor microenvironment in Hodgkin lymphoma: novel prognostic factors for assessing disease evolution.
Turbatu A; Dobrea C; Stoian M; Barta CT; Halcu G; Birceanu A; Bordea AM; Ghimici CG; Oprea MM; Neacșu LD; Lupu AR; Coliță A
J Med Life; 2023 Aug; 16(8):1201-1210. PubMed ID: 38024830
[TBL] [Abstract][Full Text] [Related]
30. Prognostic Role of the Expression of Latent-Membrane Protein 1 of Epstein-Barr Virus in Classical Hodgkin Lymphoma.
Santisteban-Espejo A; Perez-Requena J; Atienza-Cuevas L; Moran-Sanchez J; Fernandez-Valle MDC; Bernal-Florindo I; Romero-Garcia R; Garcia-Rojo M
Viruses; 2021 Dec; 13(12):. PubMed ID: 34960792
[TBL] [Abstract][Full Text] [Related]
31. Prognostic significance of CD20 expression and Epstein-Barr virus (EBV) association in classical Hodgkin lymphoma in Japan: a clinicopathologic study.
Elsayed AA; Asano N; Ohshima K; Izutsu K; Kinoshita T; Nakamura S
Pathol Int; 2014 Jul; 64(7):336-45. PubMed ID: 25047504
[TBL] [Abstract][Full Text] [Related]
32. Epstein-Barr virus infection induces an increase of T regulatory type 1 cells in Hodgkin lymphoma patients.
Morales O; Mrizak D; François V; Mustapha R; Miroux C; Depil S; Decouvelaere AV; Lionne-Huyghe P; Auriault C; de Launoit Y; Pancré V; Delhem N
Br J Haematol; 2014 Sep; 166(6):875-90. PubMed ID: 25041527
[TBL] [Abstract][Full Text] [Related]
33. Epstein-Barr virus latent membrane protein-1 up-regulates cytokines and correlates with older age and poorer prognosis in Hodgkin lymphoma.
Chang KC; Chen PC; Chang Y; Wu YH; Chen YP; Lai CH; Medeiros LJ; Su IJ; Wang HW
Histopathology; 2017 Feb; 70(3):442-455. PubMed ID: 27632954
[TBL] [Abstract][Full Text] [Related]
34. Assessment of tumor Epstein-Barr Virus status and its impact on outcomes in intermediate and high-risk childhood classic Hodgkin Lymphoma treated at a tertiary cancer center in India.
Cheriyalinkal Parambil B; Narula G; Dhamne C; Roy Moulik N; Shet T; Shridhar E; Gujral S; Shah S; Laskar S; Khanna N; Banavali S
Leuk Lymphoma; 2020 Dec; 61(13):3217-3225. PubMed ID: 32729791
[TBL] [Abstract][Full Text] [Related]
35. The relationships between Epstein-Barr virus latent membrane protein 1 and regulatory T cells in Hodgkin's lymphoma.
Marshall NA; Culligan DJ; Tighe J; Johnston PW; Barker RN; Vickers MA
Exp Hematol; 2007 Apr; 35(4):596-604. PubMed ID: 17379070
[TBL] [Abstract][Full Text] [Related]
36. The effect of Epstein-Barr virus status on clinical outcome in Hodgkin's lymphoma.
Kwon JM; Park YH; Kang JH; Kim K; Ko YH; Ryoo BY; Lee SS; Lee SI; Koo HH; Kim WS
Ann Hematol; 2006 Jul; 85(7):463-8. PubMed ID: 16534596
[TBL] [Abstract][Full Text] [Related]
37. Molecular Characterisation of Epstein-Barr Virus in Classical Hodgkin Lymphoma.
Begić V; Korać P; Gašparov S; Rozman M; Simicic P; Zidovec-Lepej S
Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555277
[TBL] [Abstract][Full Text] [Related]
38. Immunohistochemical expression of vitamin D receptor and forkhead box P3 in classic Hodgkin lymphoma: correlation with clinical and pathologic findings.
Gupta GK; Agrawal T; Pilichowska M
BMC Cancer; 2020 Jun; 20(1):535. PubMed ID: 32513132
[TBL] [Abstract][Full Text] [Related]
39. Association of DDX58 177 C > T polymorphism with decreased risk of Epstein-Barr virus-related nodular sclerosis classical Hodgkin lymphoma.
Martin P; Martínez-Velasquez J; Coronado MJ; Krsnik I; Provencio M; Navarro B; Moraru M; Bellas C; Vilches C; Gomez-Lozano N
Leuk Lymphoma; 2017 Feb; 58(2):438-444. PubMed ID: 27267403
[TBL] [Abstract][Full Text] [Related]
40. Imbalances of chemokines, chemokine receptors and cytokines in Hodgkin lymphoma: classical Hodgkin lymphoma vs. Hodgkin-like ATLL.
Ohshima K; Karube K; Hamasaki M; Suefuji H; Tutiya T; Yamaguchi T; Suzumiya J; Kikuchi M
Int J Cancer; 2003 Sep; 106(5):706-12. PubMed ID: 12866030
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]